( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Teladoc Health, Inc.

(“Teladoc” or the“Company”) (NYSE: TDOC) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Teladoc securities between November 2, 2022 and February 20, 2024, both dates inclusive (the“Class Period”). Investors have until July 16, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action.

Teladoc provides online, direct-to-consumer health service services. BetterHelp is Teladoc's largest division and contributes the Company's greatest revenue share, contributing about 42% of overall revenue. The Teladoc class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Teladoc continued to expand its marketing spend throughout 2023, despite public assurances that it would pull back its advertising spending; (ii) increased marketing spend on BetterHelp deteriorated Teladoc's revenue, with little return for that investment; (iii) despite Teladoc's acknowledgment that increased advertising spend would be marginally inefficient due to market saturation, it continued to grow its advertising spend i.